Alexza Pharmaceuticals has hired Winston R. Brown, Jr. as VP, Quality, the company has announced. Brown was most recently Global Head, Quality R&D – Pharmaceuticals, Biologics, and Vision Care Devices at Alcon Research.
The company has made several hires recently as it is in the process of commercializing its Adasuve inhaled loxapine for the treatment of agitation in schizophrenic and bi-polar patients. Adasuve was launched in the EU in 2013 and in the US earlier this year.
Alexza Executive VP Operations and COO Robert A. Lippe commented, “We are pleased to welcome Winston to our team. Winston brings extensive quality program expertise coupled with strong operational leadership experience to our company, at a time of exciting growth in both scale and scope. We look forward to his contributions in support of our efforts with the global Adasuve launch and in expanding our candidate pipeline.”
Brown added, “With the ongoing commercialization of Adasuve in the US and EU, and commercial collaborations in place with Teva and Ferrer, it is an exciting time to join Alexza. I look forward to working with Alexza’s talented employees to continue the transition from a development stage company to commercial stage company.”
Read the Alexza press release.
